蔚來(09866.HK)ET5首批生產線預生產車正式下線
蔚來(09866.HK)(NIO.US)宣布,旗下「ET5」車型首批生產線預生產(Pre-production)車輛,近日於NeoPark新橋智能電動汽車產業園區內的蔚來第二先進製造基地正式下線,標誌著生產線開始正式對車輛的小批量生產能力進行驗證,確保所有零件達到可銷售狀態,同時亦代表ET5愈來億接近真正達到可以交付給用戶朋友的狀態。
蔚來表示,現階段生產線將持續提高零部件和整車的質素狀態,並提高生產線人員的操作技能,並開展小批量量產運行驗證,最終使生產線具備量產能力。智能座艙、儀表等部件的法規認證工作,目前亦在同步進行,預期當生產線預生產階段完成後,將迎來ET5最終的量產階段(Mass Production)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.